UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer's disease individuals: replication of diastolic blood pressure correlations and analysis of critical covariates

PloS one, 2013-11, Vol.8 (11), p.e81334-e81334

2013

Volltextzugriff (PDF)

Activated Human T Cells Release Bioactive Fas Ligand and APO2 Ligand in Microvesicles

The Journal of immunology (1950), 1999-08, Vol.163 (3), p.1274-1281

1999

Volltextzugriff (PDF)

Differential Secretion of Fas Ligand- or APO2 Ligand/TNF-Related Apoptosis-Inducing Ligand-Carrying Microvesicles During Activation-Induced Death of Human T Cells

The Journal of immunology (1950), 2001-12, Vol.167 (12), p.6736-6744

2001

Volltextzugriff (PDF)

Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study

Alzheimer's research & therapy, 2019-12, Vol.11 (1), p.96-96, Article 96

2019

Volltextzugriff (PDF)

Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD

International journal of alzheimer's disease, 2012, Vol.2012 (2012), p.1-10

2012

Volltextzugriff (PDF)

Plasma β-amyloid peptides in canine aging and cognitive dysfunction as a model of Alzheimer's disease

Experimental gerontology, 2011-07, Vol.46 (7), p.590-596

2011

Volltextzugriff (PDF)

Cytotoxicity of quinone drugs on highly proliferative human leukemia T cells: Reactive oxygen species generation and inactive shortened SOD1 isoform implications

Chemico-biological interactions, 2012-06, Vol.198 (1-3), p.18-28

2012

Volltextzugriff (PDF)

A Role of the Mitochondrial Apoptosis-Inducing Factor in Granulysin-Induced Apoptosis

The Journal of immunology (1950), 2001-08, Vol.167 (3), p.1222-1229

2001

Volltextzugriff (PDF)

Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial

Alzheimer's research & therapy, 2018-01, Vol.10 (1), p.12-12, Article 12

2018

Volltextzugriff (PDF)

Several direct and calculated biomarkers from the amyloid-β pool in blood are associated with an increased likelihood of suffering from mild cognitive impairment

Journal of Alzheimer's disease, 2013-01, Vol.36 (1), p.211-219

2013

Volltextzugriff (PDF)

Saber tibia

Revista de osteoporosis y metabolismo mineral, 2023

2023

Volltextzugriff (PDF)

The clinical significance of plasmatic amyloid A{beta}-40 peptide levels in Alzheimer's disease patients treated with galantamine

American journal of Alzheimer's disease and other dementias, 2008-06, Vol.23 (3), p.286

2008

Volltextzugriff (PDF)

The Clinical Significance of Plasmatic Amyloid Aβ-40 Peptide Levels in Alzheimer's Disease Patients Treated With Galantamine

American journal of Alzheimer's disease and other dementias, 2008-06, Vol.23 (3), p.286-290

2008

Volltextzugriff (PDF)

Safety, tolerability and immunogenicity of an active anti-Aβ 40 vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial

Alzheimer's research & therapy, 2018-01, Vol.10 (1), p.12

2018

Volltextzugriff (PDF)

P2‐057: Aβ blood levels and Alzheimer's disease

Alzheimer's & dementia, 2011-07, Vol.7 (4S_Part_9), p.S325-S326

2011

Volltextzugriff (PDF)

Aβ blood levels and Alzheimer's disease

Alzheimer's & dementia, 2011-07, Vol.7 (4), p.S325-S326

2011

Volltextzugriff (PDF)

O2‐03‐05: Beta‐amyloid‐17 is a major beta‐amyloid fragment isoform in cerebrospinal fluid and blood that shows diagnostic value

Alzheimer's & dementia, 2012-07, Vol.8 (4S_Part_7), p.P240-P240

2012

Volltextzugriff (PDF)

Beta-amyloid-17 is a major beta-amyloid fragment isoform in cerebrospinal fluid and blood that shows diagnostic value

Alzheimer's & dementia, 2012-07, Vol.8 (4), p.P240-P240

2012

Volltextzugriff (PDF)

Lack of Fas/CD95 surface expression in highly proliferative leukemic cell lines correlates with loss of CtBP/BARS and redirection of the protein toward giant lysosomal structures

Cell growth & differentiation, 2002-07, Vol.13 (7), p.315-324

2002

Volltextzugriff (PDF)

Reliable Measurements of the [beta]-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD

International journal of alzheimer's disease, 2012-01, Vol.2012

2012

Volltextzugriff (PDF)

P2‐168: Early diagnosis and preventive treatment of Alzheimer's with isoform‐specific Aβ antibodies

Alzheimer's & dementia, 2010-07, Vol.6 (4S_Part_12), p.S363-S363

2010

Volltextzugriff (PDF)

Early diagnosis and preventive treatment of Alzheimer's with isoform-specific Aβ antibodies

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S363-S363

2010

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(49)

Sprache

Englisch
(46)
Spanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer's disease individuals: replication of diastolic blood pressure correlations and analysis of critical covariates

Activated Human T Cells Release Bioactive Fas Ligand and APO2 Ligand in Microvesicles

Differential Secretion of Fas Ligand- or APO2 Ligand/TNF-Related Apoptosis-Inducing Ligand-Carrying Microvesicles During Activation-Induced Death of Human T Cells

Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study

Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD

Plasma β-amyloid peptides in canine aging and cognitive dysfunction as a model of Alzheimer's disease

Cytotoxicity of quinone drugs on highly proliferative human leukemia T cells: Reactive oxygen species generation and inactive shortened SOD1 isoform implications

A Role of the Mitochondrial Apoptosis-Inducing Factor in Granulysin-Induced Apoptosis

Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial

Several direct and calculated biomarkers from the amyloid-β pool in blood are associated with an increased likelihood of suffering from mild cognitive impairment

Saber tibia

The clinical significance of plasmatic amyloid A{beta}-40 peptide levels in Alzheimer's disease patients treated with galantamine

The Clinical Significance of Plasmatic Amyloid Aβ-40 Peptide Levels in Alzheimer's Disease Patients Treated With Galantamine

Safety, tolerability and immunogenicity of an active anti-Aβ 40 vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial

Plasma A[beta]42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study

Correction: Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates

P2‐057: Aβ blood levels and Alzheimer's disease

Aβ blood levels and Alzheimer's disease

O2‐03‐05: Beta‐amyloid‐17 is a major beta‐amyloid fragment isoform in cerebrospinal fluid and blood that shows diagnostic value

Beta-amyloid-17 is a major beta-amyloid fragment isoform in cerebrospinal fluid and blood that shows diagnostic value

Lack of Fas/CD95 surface expression in highly proliferative leukemic cell lines correlates with loss of CtBP/BARS and redirection of the protein toward giant lysosomal structures

Reliable Measurements of the [beta]-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD

P2‐168: Early diagnosis and preventive treatment of Alzheimer's with isoform‐specific Aβ antibodies

Early diagnosis and preventive treatment of Alzheimer's with isoform-specific Aβ antibodies

Correction: Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates

Suchergebnisse filtern